A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas

Journal of the American Academy of Dermatology

Volumn 42, Issue 3, 2000, Pages 496-500

  Bergman, Reuven ^a,b   Azzam, Halim ^a   Sprecher, Eli ^a   Manov, Lena ^a   Munichor, Mariana ^a   Friedman Birnbaum, Rachel ^a   Ben Itzhak, Offer ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL;

EID: 0033924876     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90226-3     Document Type: Article

References (16)

1. Busam KJ, Iversen K, Coplan KA, Old LJ, Stockert E, Chen Y-T, et al. Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 1998;22:57-63.
2. Kageshita T, Kawakami Y, Hirari S, Ono T. Differential expression of MART-1 in primary and metastatic melanoma lesions. J Immunotherapy 1997;20:460-5.
3. Kawakami Y, Battles JK, Kobayashi T, Ennis W, Wang X, Tupesis JP, et al. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1. J Immunol Methods 1997;202:13-25.
4. Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, et al. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in situ lesions. J Immunother 1996;19:192-205.
5. de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GNP. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 1997;57:3223-9.
6. Fetsch PA, Cormier J, Hijazi M. Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas. J Immunother 1997;20:60-4.
7. Nicorta MR, Nistico P, Mangoni A, Filippo FD, Marincola FM, Natali PG. Melan-A/MART-1 antigen expression in cutaneous and ocular melanomas. J Immunother 1997;20:466-9.
8. Busam KJ, Chen Y-T, Old LJ, Stockert E, Iversen K, Coplan KA, et al. Expression of Melan-A (MART 1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 1998;22:976-82.
9. Jungbluth AA, Busam KJ, Gerald WL, Stockert E, Coplan KA, Iversen K, et al. An anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 1998;22:595-602.
10. Maize JC, Ackerman AB. Pigmented lesions of the skin. Philadelphia: Lea & Febiger; 1987. p. 236.
11. Goovaerts G, Buyssens N. Nevus cell maturation or atrophy? Am J Dermatopathol 1988;10:20-7.
12. Bergman R, Dromi R, Trau H, Cohen I, Lichtig C. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol 1995;17:542-6.
13. Kawakami Y, Eliyahu S, Delgado CH, Robins RF, Sakaguchi K, Appela E, et al. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A 1994;91:6458-62.
14. Sensi M, Traversari C, Radrizzani M, Salvi S, Maccalli C, Mortarini R, et al. Cytotoxic T lymphocyte clones from different patients display limited T-cell receptors variable gene usage in HLA-A2 restricted recognition of Melan/MART-1 melanoma antigen. Proc Natl Acad Sci U S A 1995;92:5674-8.
15. Bonetti F, Pea M, Martignoni G, Mombello A, Colombari R, Zamboni G, et al. False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of anti-melanoma monoclonal antibody HMB45. Am J Clin Pathol 1991;95:454-9.
16. Orloff LA, Weymuller EA, Flaherty MJ. Papillary thyroid carcinoma mistaken for malignant melanoma: pitfalls in diagnosis. Head Neck 1995;17:157-60.